• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Struct Mol Biol . TMPRSS2-mediated coronavirus spike activation and inhibition

tetano

Editor, Senior Moderator
Nat Struct Mol Biol


. 2026 Apr 28.
doi: 10.1038/s41594-026-01801-y. Online ahead of print.
TMPRSS2-mediated coronavirus spike activation and inhibition

Matthew McCallum[SUP] #[/SUP][SUP] 1 2 [/SUP], James Brett Case[SUP] #[/SUP][SUP] 3 4 [/SUP], Jack T Brown[SUP] #[/SUP][SUP] 1 [/SUP], Young-Jun Park[SUP] #[/SUP][SUP] 1 5 [/SUP], Jimin Lee[SUP] 1 [/SUP], Emmajay Sutherland[SUP] 6 [/SUP], Anupriya Aggarwal[SUP] 7 [/SUP], Cecily Gibson[SUP] 1 5 [/SUP], Florian A Lempp[SUP] 8 [/SUP], Cameron Stewart[SUP] 1 [/SUP], M Alejandra Tortorici[SUP] 1 [/SUP], Shilpa Sanapala[SUP] 3 [/SUP], Jun Siong Low[SUP] 9 10 11 [/SUP], Daniel Asarnow[SUP] 1 [/SUP], Dana Bohan[SUP] 8 [/SUP], Exequiel Dellota Jr[SUP] 8 [/SUP], Benjamin Merz[SUP] 1 [/SUP], Bhavna Chawla[SUP] 12 [/SUP], Swagata Kar[SUP] 12 [/SUP], Antonio Lanzavecchia[SUP] 13 14 [/SUP], Federica Sallusto[SUP] 9 10 [/SUP], Nicholas M Riley[SUP] 6 [/SUP], Stuart Turville[SUP] 7 [/SUP], Lisa Purcell[SUP] 8 15 [/SUP], Michael S Diamond[SUP] 16 17 18 [/SUP], David Veesler[SUP] 19 20 [/SUP]


Affiliations
Abstract

The protease TMPRSS2 facilitates coronavirus infections, yet its mechanism of viral glycoprotein recognition remains unclear. Here we show that, following ACE2 engagement of the SARS-CoV-2 spike (S) inducing the early fusion intermediate conformation (E-FIC), TMPRSS2 cleaves the R815 S[SUB]2[/SUB]' site and promotes fusogenic conformational changes leading to viral entry. We unveil TMPRSS2 recognition of S[SUB]2[/SUB]', identify key residues modulating binding specificity and demonstrate that S[SUB]2[/SUB]' site-directed broadly neutralizing antibodies target E-FIC and inhibit viral entry by blocking TMPRSS2 access. We computationally designed stabilized E-FIC as a vaccine candidate, overcoming the transient nature of this state. We describe a TMPRSS2-directed monoclonal antibody inhibiting several coronaviruses, including SARS-CoV-2 variants and protecting mice against SARS-CoV-2 challenge. These results outline the mechanistic role of TMPRSS2 and S[SUB]2[/SUB]' site-directed antibodies in coronavirus entry.


 
Back
Top